Fresenius Kabi starts work on $250m US sterile drug plant

By Gareth Macdonald

- Last updated on GMT

Related tags Manufacturing

Fresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at groundbreaking ceremony
Fresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at groundbreaking ceremony
Fresenius Kabi has started work on a $250m (€220m) sterile drug manufacturing plant in Illinois, US.

The German drug manufacturer announced plans for facility last year​, explaining that construction at the site in Chicago’s Melrose Park suburb will help it capture a greater share of the US injectables market.

The project will create several manufacturing suites equipped with automated aseptic filling lines, expanded lyophilization capabilities, and formulation areas, as well as a dedicated warehouse for raw materials.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us

Webinars

Headlines